- Current report filing (8-K)
2013年1月17日 - 6:12AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of
1934
Date of report (Date of earliest event reported): January 10, 2013
IDEXX LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-19271
|
|
01-0393723
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
One IDEXX Drive, Westbrook, Maine
|
|
04092
|
(Address of principal executive offices)
|
|
(ZIP Code)
|
207.556.0300
(Registrants telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. to
Form 8-K):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02.
|
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
|
(b) On January 10, 2013, Merilee Raines, our Executive Vice President and Chief Financial Officer, announced her intention to retire from the Company
after 28 years of service. Ms. Raines will remain with the Company through its Annual Meeting of Stockholders, which will be held on May 8, 2013, to assist in transition. The Company has commenced a search for Ms. Raines
successor.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
IDEXX LABORATORIES, INC.
|
|
|
|
|
Date: January 16, 2013
|
|
|
|
By:
|
|
/s/ Jonathan W. Ayers
|
|
|
|
|
|
|
Jonathan W. Ayers
|
|
|
|
|
|
|
Chairman, President, and Chief Executive Officer
|
3
IDEXX Laboratories (NASDAQ:IDXX)
過去 株価チャート
から 6 2024 まで 7 2024
IDEXX Laboratories (NASDAQ:IDXX)
過去 株価チャート
から 7 2023 まで 7 2024